FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers

FDA authorizes 20 ZYN products in nicotine bags, highlighting lower risk than cigarettes and potential to help leave the most harmful tobacco

The U.S. Food and Drug Administration (FDA) authorized the marketing of Zyn’s nicotine bags, owned by Philip Morris, to help smokers reduce or stop cigarette consumption. Ten flavors approved by the federal agency, including coffee, mint and menthol. The FDA determined that these Zyn products meet all the requirements of the public health standard of the 2009 Tobacco Control and Prevention of Family Tobacco Act. This provision considers the pote…

FDA Approves Marketing of Nicotine Pouches

FRIDAY, Jan. 17, 2025 (HealthDay News) -- Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed…

Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.

FDA authorizes marketing of nicotine pouches for the first time

These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.

Thursday's decision allows 10 Zyn flavors, including mint, coffee, cinnamon and menthol, to be available on the market, writes the BBC.The sachets, which are manufactured by tobacco giant Phillip Morris, have been on the market for U.S. adults for more than a decade, when the FDA considered allowing them to be officially commercialized.Nicotine bags do not contain real tobacco, unlike other forms of oral nicotine, and have exploded in popularity…